Robert Bosch Gesellschaft für Medizinische Forschung

The Robert Bosch Gesellschaft für Medizinische Forschung (RBMF) is a leading German research institution dedicated to translational medicine and clinical pharmacology. Based in Stuttgart and integrated into the Bosch Health Campus, the organization operates in close affiliation with the Robert Bosch Hospital to translate laboratory findings into clinical applications. Its core research unit, the Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology (IKP), is internationally recognized for its work in pharmacogenomics and personalized medicine. The RBMF focuses on optimizing drug therapies and understanding the genetic basis of drug response, particularly in the fields of oncology and cardiovascular health. Through its multidisciplinary approach, the institute aims to improve patient outcomes by developing individualized treatment strategies based on molecular and genetic profiling.